Hepatosplenic and other γδ T-cell lymphomas

American Journal of Clinical Pathology

Volumn 127, Issue 6, 2007, Pages 869-880

  Vega, Francisco ^a   Medeiros, L Jeffrey ^a   Gaulard, Philippe ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b HENRI MONDOR HOSPITAL   (France)

Author keywords

T cell lymphoma; Hepatosplenic T cell lymphoma; T cell neoplasms; WHO classification; Workshop 2005, Houston

Indexed keywords

T LYMPHOCYTE RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR;

BONE MARROW; CANCER INFILTRATION; CLINICAL FEATURE; CONFERENCE PAPER; CYTOGENETICS; CYTOPENIA; CYTOTOXIC T LYMPHOCYTE; GENE EXPRESSION; HEPATOSPLENIC T CELL LYMPHOMA; HEPATOSPLENOMEGALY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; ISOCHROMOSOME; ISOCHROMOSOME 7Q; LIVER SINUSOID; LYMPHOCYTE PROLIFERATION; PERIPHERAL T CELL LYMPHOMA; PHENOTYPE; PRIORITY JOURNAL; RARE DISEASE; RECURRENCE RISK; T CELL LYMPHOMA; T LYMPHOCYTE ACTIVATION; TUMOR CELL; FLOW CYTOMETRY; IMMUNOLOGY; LIVER TUMOR; METABOLISM; PATHOLOGY; SPLEEN TUMOR; T LYMPHOCYTE; WORLD HEALTH ORGANIZATION;

FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; LIVER NEOPLASMS; LYMPHOMA, T-CELL, PERIPHERAL; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; SPLENIC NEOPLASMS; T-LYMPHOCYTES; WORLD HEALTH ORGANIZATION;

EID: 34250625241     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/LRKX8CE7GVPCR1FT     Document Type: Conference Paper

References (39)

1. Kadin ME, Kamoun M, Lamberg J. Erythrophagocytic T gamma lymphoma: a clinicopathologic entity resembling malignant histiocytosis. N Engl J Med. 1981;304:648-653.
2. Farcet JP, Gaulard P, Marolleau JP, et al. Hepatosplenic T-cell lymphoma: sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta. Blood. 1990;75:2213-2219.
3. Gaulard P, Bourquelot P, Kanavaros P, et al. Expression of the alpha/beta and gamma/delta T-cell receptors in 57 cases of peripheral T-cell lymphomas; identification of a subset of gamma/delta T-cell lymphomas. Am J Pathol. 1990;137:617-628.
4. Bucy RP, Chen CL, Cooper MD. Tissue localization and CD8 accessory molecule expression of T gamma delta cells in humans. J Immunol. 1989;142:3045-3049.
5. Bordessoule D, Gaulard P, Mason DY. Preferential localisation of human lymphocytes bearing gamma delta T cell receptors to the red pulp of the spleen. J Clin Pathol. 1990;43:461-464.
6. Garcia-Sanchez F, Menarguez J, Cristobal E, et al. Hepatosplenic gamma-delta T-cell malignant lymphoma: report of the first case in childhood, including molecular minimal residual disease follow-up. Br J Haematol. 1995;90:943-946.
7. Wong KF, Chan JK, Matutes E, et al. Hepatosplenic gamma delta T-cell lymphoma: a distinctive aggressive lymphoma type. Am J Surg Pathol. 1995;19:718-726.
8. Belhadj K, Reyes F, Farcet JP, et al. Hepatosplenic γδ T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients. Blood. 2003;102:4261-4269.
9. Francois A, Lesesve JF, Stamatoullas A, et al. Hepatosplenic gamma/delta T-cell lymphoma: a report of two cases in immunocompromised patients, associated with isochromosome 7q. Am J Surg Pathol. 1997;21:781-790.
10. Wu H, Wasik MA, Przybylski G, et al. Hepatosplenic gamma-delta T-cell lymphoma as a late-onset posttransplant lymphoproliferative disorder in renal transplant recipients. Am J Clin Pathol. 2000;113:487-496.
11. Khan WA, Yu L, Eisenbrey AB, et al. Hepatosplenic gamma/delta T-cell lymphoma in immunocompromised patients: report of two cases and review of literature. Am J Clin Pathol. 2001;116:41-50.
12. Steurer M, Stauder R, Grunewald K, et al. Hepatosplenic gammadelta-T-cell lymphoma with leukemic course after renal transplantation. Hum Pathol. 2002;33:253-258.
13. Vega F, Medeiros LJ, Bueso-Ramos C, et al. Hepatosplenic gamma/delta T-cell lymphoma in bone marrow; a sinusoidal neoplasm with blastic cytologic features. Am J Clin Pathol. 2001;116:410-419.
14. Aldinucci D, Poletto D, Zagonel V, et al. In vitro and in vivo effects of 2′-deoxycoformycin (pentostatin) on tumour cells from human gammadelta+ T-cell malignancies. Br J Haematol. 2000;110:188-196.
15. Nosari A, Oreste PL, Biondi A, et al. Hepato-splenic gammadelta T-cell lymphoma: a rare entity mimicking the hemophagocytic syndrome. Am J Hematol. 1999;60:61-65.
16. Jones D, Vega F, Sarris AH, et al. CD4-CD8-"double-negative" cutaneous T-cell lymphomas share common histologic features and an aggressive clinical course. Am J Surg Pathol. 2002;26:225-231.
17. Lai R, Larratt LM, Etches W, et al. Hepatosplenic T-cell lymphoma of alphabeta lineage in a 16-year-old boy presenting with hemolytic anemia and thrombocytopenia. Am J Surg Pathol. 2000;24:459-463.
18. Macon WR, Levy NB, Kurtin PJ, et al. Hepatosplenic alphabeta T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas. Am J Surg Pathol. 2001;25:285-296.
19. Suarez F, Wlodarska I, Rigal-Huguet F, et al. Hepatosplenic alphabeta T-cell lymphoma: an unusual case with clinical, histologic, and cytogenetic features of gammadelta hepatosplenic T-cell lymphoma. Am J Surg Pathol. 2000;24:1027-1032.
20. Cooke CB, Krenacs L, Stetler-Stevenson M, et al. Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin. Blood. 1996;88:4265-4274.
21. Boulland ML, Kanavaros P, Wechsler J, et al. Cytotoxic protein expression in natural killer cell lymphomas and in alpha beta and gamma delta peripheral T-cell lymphomas. J Pathol. 1997;183:432-439.
22. Krenacs L, Smyth MJ, Bagdi E, et al. The serine protease granzyme M is preferentially expressed in NK-cell, gamma delta T-cell, and intestinal T-cell lymphomas: evidence of origin from lymphocytes involved in innate immunity. Blood. 2003;101:3590-3593.
23. Ohshima K, Haraoka S, Harada N, et al. Hepatosplenic gammadelta T-cell lymphoma: relation to Epstein-Barr virus and activated cytotoxic molecules. Histopathology. 2000;36:127-135.
24. Alonsozana EL, Stamberg J, Kumar D, et al. Isochromosome 7q: the primary cytogenetic abnormality in hepatosplenic gammadelta T cell lymphoma. Leukemia. 1997;11:1367-1372.
25. Wlodarska I, Martin-Garcia N, Achten R, et al. Fluorescence in situ hybridization study of chromosome 7 aberrations in hepatosplenic T-cell lymphoma: isochromosome 7q as a common abnormality accumulating in forms with features of cytologic progression. Genes Chromosomes Cancer. 2002;33:243-251.
26. Przybylski GK, Wu H, Macon WR, et al. Hepatosplenic and subcutaneous panniculitis-like gamma/delta T cell lymphomas are derived from different Vdelta subsets of gamma/delta T lymphocytes. J Mol Diagn. 2000;2:11-19.
27. Arnulf B, Copie-Bergman C, Delfau-Larue MH, et al. Nonhepatosplenic gammadelta T-cell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localization. Blood. 1998;91:1723-1731.
28. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105:3768-3785.
29. Gonzalez CL, Medeiros LJ, Braziel RM, et al. T-cell lymphoma involving subcutaneous tissue: a clinicopathologic entity commonly associated with hemophagocytic syndrome. Am J Surg Pathol. 1991;15:17-27.
30. Sen F, Rassidakis GZ, Jones D, et al. Apoptosis and proliferation in subcutaneous panniculitis-like T-cell lymphoma. Mod Pathol. 2002;15:625-631.
31. Felgar RE, Salhany KE, Macon WR, et al. The expression of TIA-1+ cytolytic-type granules and other cytolytic lymphocyte-associated markers in CD30+ anaplastic large cell lymphomas (ALCL): correlation with morphology, immunophenotype, ultrastructure, and clinical features. Hum Pathol. 1999;30:228-236.
32. Vermeer MH, Geelen FA, Kummer JA, et al. Expression of cytotoxic proteins by neoplastic T cells in mycosis fungoides increases with progression from plaque stage to tumor stage disease. Am J Pathol. 1999;154:1203-1210.
33. Osuji N, Matutes E, Tjonnfjord G, et al. T-cell large granular lymphocyte leukemia: a report on the treatment of 29 patients and a review of the literature. Cancer. 2006;107:570-578.
34. Morice WG, Kurtin PJ, Tefferi A, et al. Distinct bone marrow findings in T-cell granular lymphocytic leukemia revealed by paraffin section immunoperoxidase stains for CD8, TIA-1, and granzyme B. Blood. 2002;99:268-274.
35. Loughran TP Jr. Clonal diseases of large granular lymphocytes. Blood. 1993;82:1-14.
36. Vie H, Chevalier S, Garand R, et al. Clonal expansion of lymphocytes bearing the gamma delta T-cell receptor in a patient with large granular lymphocyte disorder. Blood. 1989;74:285-290.
37. Saito T, Togitani K, Murakami J, et al. Granular lymphocytic leukemia derived from gamma delta T-cell expressing cytotoxic molecules. Leuk Res. 2001;25:259-261.
38. Chan JK, Sin VC, Wong KF, et al. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood. 1997;89:4501-4513.
39. Morice WG, Macon WR, Dogan A, et al. NK-cell-associated receptor expression in hepatosplenic T-cell lymphoma, insights into pathogenesis. Leukemia. 2006;20:883-886.